Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Sees Large Growth in Short Interest

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 85,900 shares, a growth of 560.8% from the October 15th total of 13,000 shares. Based on an average daily volume of 266,400 shares, the short-interest ratio is presently 0.3 days.

Shionogi & Co., Ltd. Price Performance

SGIOY traded down $0.08 during trading on Tuesday, reaching $6.85. The stock had a trading volume of 274,993 shares, compared to its average volume of 147,612. The firm has a market capitalization of $12.19 billion, a price-to-earnings ratio of 11.75, a price-to-earnings-growth ratio of 5.52 and a beta of 0.22. The company has a quick ratio of 5.37, a current ratio of 5.86 and a debt-to-equity ratio of 0.01. Shionogi & Co., Ltd. has a 1-year low of $6.22 and a 1-year high of $9.11. The stock has a 50 day moving average of $8.74 and a two-hundred day moving average of $10.04.

Shionogi & Co., Ltd. Company Profile

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.